ArticleFrontiers in oncology2024

Case report: Response to tepotinib in Chinese non-small cell lung cancer patients harboring METex14 skipping with varying features.

Yan Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.